4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-001576
Chief Discovery/Trans Medicine sold 7,940 shares at an average $36.89 ($292,904)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamilton James C Chief Discovery/Trans Medicine | 2024-01-12 | Sale 10b5-1 | −4,238 | $36.47 | $154,560 | 214,553 | D |
| Hamilton James C Chief Discovery/Trans Medicine | 2024-01-12 | Sale 10b5-1 | −3,702 | $37.37 | $138,344 | 210,851 | D |
| Open-market sales · 7,940 sh · avg $36.89 · $292,904 | |||||||
Loading xslF345X05/wk-form4_1705534331.xml…